8-K: Cycurion, Inc. Faces Nasdaq Delisting Threat Due to Minimum Bid Price and Market Value Deficiencies
8-K Filing
Cycurion, Inc. received notices from Nasdaq regarding non-compliance with minimum bid price and market value requirements, potentially leading to delisting.
Summary
- Cycurion, Inc. received a notice from Nasdaq on April 9, 2025, stating that it no longer meets the minimum bid price requirement of $1.00 per share for continued listing.
- The company has a 180-day period, expiring on October 6, 2025, to regain compliance by maintaining a closing bid price of at least $1.00 for a minimum of ten consecutive business days.
- Cycurion received two additional letters from Nasdaq on April 11, 2025, regarding deficiencies in the Market Value of Listed Securities (MVLS) and Market Value of Publicly Held Shares (MVPHS).
- The company's MVLS was below the required $50,000,000 minimum, and its MVPHS was below the required $15,000,000 minimum for 30 consecutive business days.
- Cycurion has until October 8, 2025, to regain compliance with both the MVLS and MVPHS requirements by maintaining the minimum values for at least 10 consecutive business days.
- Failure to regain compliance with any of these requirements could result in the delisting of Cycurion's securities from Nasdaq, although the company has the right to appeal such a decision.
- Cycurion is evaluating potential actions to regain compliance with all applicable requirements for continued listing on The Nasdaq Global Market.
- There is no assurance that the company will be successful in maintaining its listing.
Sentiment
Score: 3
Explanation: The sentiment is negative due to the delisting warnings from Nasdaq, indicating financial distress and uncertainty about the company's future.
Positives
- The Nasdaq Notices have no immediate effect on the company's continued listing on The Nasdaq Global Market or the trading of the company's common stock, subject to the company's compliance with the other continued listing requirements.
- The company has the right to appeal any delisting determination to a Nasdaq hearings panel.
Negatives
- Cycurion's common stock is at risk of being delisted from the Nasdaq Global Market.
- The company has failed to meet the minimum bid price, Market Value of Listed Securities, and Market Value of Publicly Held Shares requirements for continued listing.
- There is no assurance that the company will be successful in maintaining its listing on The Nasdaq Global Market.
Risks
- Failure to regain compliance with Nasdaq's listing requirements could result in the delisting of Cycurion's common stock.
- Delisting could negatively impact the company's stock price and its ability to raise capital.
- The company's ability to regain compliance is uncertain.
Future Outlook
The Company is presently evaluating potential actions to regain compliance with all applicable requirements for continued listing on The Nasdaq Global Market. There can be no assurance that the Company will be successful in maintaining the listing of its common stock on The Nasdaq Global Market.
Management Comments
- The Company is presently evaluating potential actions to regain compliance with all applicable requirements for continued listing on The Nasdaq Global Market.
Industry Context
Many smaller companies, especially those in volatile sectors like technology or biotechnology, face challenges in maintaining the minimum listing requirements of major exchanges like Nasdaq. This often leads to reverse stock splits or other measures to boost share prices.
Comparison to Industry Standards
- Companies like Digital Ally and Sonim Technologies have faced similar delisting warnings from Nasdaq due to low stock prices.
- Reverse stock splits are a common strategy employed by companies facing delisting, as seen with companies like FuelCell Energy and Ocugen.
- The 180-day compliance period is standard for Nasdaq listing deficiency notices, providing companies with a window to improve their financial metrics.
Stakeholder Impact
- Shareholders may experience a decline in the value of their investment if the company is delisted.
- Employees may face uncertainty about their jobs if the company's financial situation worsens.
- The company's ability to raise capital and fund its operations may be negatively impacted.
Next Steps
- Cycurion will evaluate potential actions to regain compliance with Nasdaq listing requirements.
- The company may consider a reverse stock split to increase its share price.
- Cycurion will need to maintain a minimum bid price of $1.00 and meet the MVLS and MVPHS requirements for at least 10 consecutive business days before October 6 and October 8, 2025, respectively.
Key Dates
| Date | Description |
|---|---|
| 2025-04-09 | Date of the First Nasdaq Notice regarding minimum bid price deficiency. |
| 2025-04-11 | Date the Company received the Second and Third Nasdaq Notices regarding MVLS and MVPHS deficiencies. |
| 2025-04-15 | Date of report. |
| 2025-10-06 | Expiration date for the 180-day period to regain compliance with the minimum bid price rule. |
| 2025-10-08 | Expiration date for the 180-day period to regain compliance with the MVLS and MVPHS rules. |
Keywords
Delisting, Nasdaq, Compliance, Minimum Bid Price, Market Value, MVLS, MVPHS, Cycurion, Listing Rules
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.